Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
11/2000
11/16/2000WO2000067569A1 A process of cell reprogramming through production of a heterokaryon
11/16/2000WO2000067568A1 A process of cell reprogramming through production of a heterokaryon
11/16/2000WO2000053633A3 Antibody and chemokine constructs that are directed to ccr5, and their use for treating autoimmune diseases
11/16/2000WO2000047223A3 Viral vaccine
11/16/2000WO2000044389A3 Method for preparing membrane vesicles
11/16/2000WO2000042191A3 Neisseria meningitidis antigenic polypeptides, corresponding polynucleotides and protective antibodies
11/16/2000WO2000042179A3 Complex-forming proteins
11/16/2000WO2000041717A3 Chorionic gonadotropin dna vaccines and methods
11/16/2000WO2000039287A3 A. fumigatus acetyl coenzyme-a carboxylase genes and polypeptides and uses thereof
11/16/2000WO2000039285A3 Human glycosylphosphatidylinositol specific phospholipase d variants and uses thereof
11/16/2000WO2000037639A3 Lymphocytic membrane proteins
11/16/2000WO2000037613A3 Human akt-3
11/16/2000WO2000037025A3 Antibodies to truncated vegf-d and uses thereof
11/16/2000WO2000036118A3 HUMAN CYCLIN-DEPENDENT KINASE (hPNQALRE)
11/16/2000WO2000036110A3 Plant disease resistance genes
11/16/2000WO2000034511A3 Aβ-PEPTIDE SCREENING ASSAY
11/16/2000WO2000031237A3 Method of cloning porcine animals
11/16/2000WO2000029603A3 Low cost manufacture of oligosaccharides
11/16/2000WO2000029561A3 Nucleotide construct with optimised codons for an hiv genetic vaccine based on a primary, early hiv isolate and synthetic envelope
11/16/2000WO2000029012A3 Methods of alleviating cancer symptoms
11/16/2000WO2000026370A3 Adenine nucleotide translocator (ant) fusion proteins and uses thereof
11/16/2000WO2000026241A3 Novel compositions and methods of screening for t-cell and b-cell activation modulators
11/16/2000WO2000023621A3 Visualization of rna in living cells
11/16/2000WO2000023466A3 Human rna binding proteins
11/16/2000WO2000020448A3 Nlk1 -interacting proteins
11/16/2000WO2000018916A3 Human genes and gene expression products
11/16/2000WO2000009706A3 Maize cellulose synthases and uses thereof
11/16/2000WO2000009549A3 Peripheral-type benzodiazepine receptor associated proteins, cloning, expression and methods of use
11/16/2000WO2000007432A9 Biodegradable high oxidative stability oils
11/16/2000WO2000006717A9 Improved transformation efficiency in phage display through modification of a coat protein
11/16/2000WO2000005375A9 Gbs toxin receptor
11/16/2000WO2000001713A3 Diacylglycerol acyl transferase proteins
11/16/2000WO2000000158A3 Alkylamines and their precursors as specific modulators of human gamma-delta t cell function
11/16/2000DE19943205C1 Production, transport and elimination of biochemical substances using an apparatus comprising cells immobilized in polar orientation between two membranes, e.g. for use as a biohybrid organ
11/16/2000DE19921693A1 Pharmaceutical composition for treating respiratory disorders, e.g. asthma, comprises combination of anticholinergic and beta-mimetic agents having synergistic bronchospasmolytic activity and reduced side-effects
11/16/2000CA2388092A1 Stereoselective antifibrillogenic peptides and peptidomimetics thereof
11/16/2000CA2374237A1 Compositions and methods for identifying antigens which elicit an immune response
11/16/2000CA2373759A1 Serine proteases
11/16/2000CA2373631A1 Monoclonal antibody directed against cells of human renal cell carcinoma
11/16/2000CA2373550A1 Methods of identifying therapeutic compounds in a genetically defined setting
11/16/2000CA2373507A1 Prp-like gene
11/16/2000CA2373135A1 Novel thermostable alkaliphilic xylanase
11/16/2000CA2373121A1 Vector-mediated delivery of integrating transposon sequences
11/16/2000CA2372968A1 Whole cell assay for cathepsin k
11/16/2000CA2372902A1 Rad51-like orthologues and uses thereof
11/16/2000CA2372881A1 Novel nucleic acids and proteins with p53 activity and altered tetramerization domains
11/16/2000CA2372871A1 Novel nucleic acids and proteins with growth hormone activity
11/16/2000CA2372837A1 Cytokine receptor mouse zcytor10
11/16/2000CA2372815A1 Extracellular matrix and adhesion-associated proteins
11/16/2000CA2372805A1 Autotaxin variants and uses to treat diseases of metabolism
11/16/2000CA2372699A1 Methods for treating tumors using antiangiogenic compounds
11/16/2000CA2372635A1 A process of cell reprogramming through production of a heterokaryon
11/16/2000CA2372597A1 Human gabab receptor 1 promoters
11/16/2000CA2372213A1 Antibodies and peptides for detection of plasmodium vivax
11/16/2000CA2371902A1 Novel nucleic acids and proteins with interferon-beta activity
11/16/2000CA2371279A1 Recombinant vaccine against botulinum neurotoxin
11/16/2000CA2371195A1 Cells and assays
11/16/2000CA2371193A1 Family of immunoregulators designated leukocyte immunoglobulin-like receptors (lir)
11/16/2000CA2369422A1 Regulation of viral gene expression
11/16/2000CA2336437A1 A process of cell reprogramming through production of a heterokaryon
11/15/2000EP1052286A2 Growth hormone and growth hormone releasing hormone compositions
11/15/2000EP1052285A2 Method of inducing an antigen-specific anticytotoxic cell
11/15/2000EP1051907A1 Extender for cryopreserving bovine sperm
11/15/2000EP1051625A1 Assessing risk for integrin antagonist/agonist mediated diseases
11/15/2000EP1051514A1 Method of isolation of rna-binding compounds
11/15/2000EP1051508A1 Pancreatic eukaryotic translation initiation factor-2alpha kinase
11/15/2000EP1051507A1 Antigen-specific cells, methods of generating these cells and uses thereof
11/15/2000EP1051504A2 Riboflavin biosynthesis genes from plants and uses thereof
11/15/2000EP1051502A2 HIGHLY EFFICIENT CONTROLLED EXPRESSION OF EXOGENOUS GENES IN $i(E. COLI)
11/15/2000EP1051500A2 Diagnosis and treatment of aur1 and/or aur2 related disorders
11/15/2000EP1051497A2 Human protein kinase molecules
11/15/2000EP1051496A1 Whisker-mediated transformation of plant cell aggregates and plant tissues and regeneration of plants thereof
11/15/2000EP1051494A1 Methods and reagents for decreasing allergic reactions
11/15/2000EP1051490A2 Modulation of cell proliferation, methods and reagents
11/15/2000EP1051489A2 Compounds for therapy and diagnosis of lung cancer and methods for their use
11/15/2000EP1051488A2 Human growth factor homologs
11/15/2000EP1051486A1 Gtpase derived from human lymph nodes that effects the morphology and cytoskeleton organization of endothelial cells
11/15/2000EP1051481A1 Secreted proteins and polynucleotides encoding them
11/15/2000EP1051479A1 Novel steroid-activated nuclear receptors and uses therefor
11/15/2000EP1051434A1 G protein-coupled receptor
11/15/2000EP1051429A1 Ldl related protein and uses thereof
11/15/2000EP1051428A1 Human cystatin f
11/15/2000EP1051427A1 Spoil protein and nucleic acid molecules and uses therefor
11/15/2000EP1051426A1 67 human secreted proteins
11/15/2000EP1051244A1 Method and articles for transfection of genetic material
11/15/2000EP1011694A4 Conditioning for allogeneic stem cell transplantation
11/15/2000EP0832191A4 Recombinant viral nucleic acids
11/15/2000EP0828826A4 Plant promoter activated by fungal infection
11/15/2000EP0765343B1 MONOCLONAL ANTIBODY ACTIVE AGAINST CD44v6
11/15/2000EP0716710B1 Methods of suppressing immune response by gene therapy
11/15/2000CN1273606A The use of mixed duplex oligonucleotides to effect localized genetic changes in plants
11/15/2000CN1273601A Enzymes mixture
11/15/2000CN1273600A Avian primordial germ cell (PGC) cell line and method for long term culturing thereof
11/15/2000CN1273599A Production of avian embryonic germ (EG) cell lines by prolonged culturing of PGCs,use thereof for cloning and chimerization
11/15/2000CN1273588A Amino acid sequences for therapeutical and prophylacticapplications to disedses due to i (clostridium difficile) toxinc
11/15/2000CN1273506A Regeneration system for grape and uses thereof
11/15/2000CN1058525C Transgene mammal cell system representing protein in surface antigen of hepatitis B virus
11/14/2000US6147282 Method of controlling the fertility of a plant
11/14/2000US6147280 Preparing carbohydrates with reduced polymerization activity; transforming plant cell with an expression construct which codes a fructosyltransferase, regenerate transgenic plant, culture transgenic plant and isolate carbohydrates
11/14/2000US6147277 Nucleotide sequences which encode an enzymatic protein associate with hydrolysis of starch; for use during horticulture and preferential plant selection
1 ... 1469 1470 1471 1472 1473 1474 1475 1476 1477 1478 1479 1480 1481 1482 1483 1484 1485 1486 1487 1488 1489 ... 1827